Efavirenz Completed Phase 4 Trials for Kaposi s Sarcoma (KS) / Human Immunodeficiency Virus (HIV) Infections Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT00444379Anti-Retrovirals for Kaposi's Sarcoma
NCT01190293PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen
NCT00457665Mechanisms of Lipodystrophy in HIV-Infected Pateints
NCT00442962HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
NCT00084136Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
NCT00532168Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
NCT00365612Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
NCT00256828Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
NCT00870363A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy
NCT00344760A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy
NCT00414635FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
NCT00224458Combination of Efavirenz and Truvada - COMET Study
NCT00615745ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla
NCT00615810ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
NCT02632474ART Drug Dosage Adjustment in HIV-infected Population
NCT00004585A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
NCT00005018Safety and Effectiveness of a Combination Anti-HIV Drug Treatment